Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | ELANE | P08246 | 1/20 | 0.56 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.56 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.56 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | CES1 | P23141 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31237097 | 1.00 | POLB (0.62) | POLBSMN1; SMN2TDP1LMNANPC1 | |
| SCHEMBL7471102 | 0.91 | POLB (0.54) | POLBSMN1; SMN2TDP1LMNANPC1 | |
| SCHEMBL23817385 | 0.87 | NPC1 (0.52) | POLBSMN1; SMN2TDP1LMNANPC1 | |
| SCHEMBL110276 | 0.87 | CYP4F2 (0.65) | SMN1; SMN2LMNANPC1CYP4F2CYP4A11 | |
| SCHEMBL522694 | 0.86 | LMNA (0.64) | POLBSMN1; SMN2TDP1LMNANPC1 | |
| SCHEMBL6028173 | 0.86 | RAB9A (0.66) | POLBSMN1; SMN2TDP1LMNANPC1 | |
| SCHEMBL29427226 | 0.85 | CYP4F2 (0.63) | POLBSMN1; SMN2NPC1CYP4F2CYP4A11 | |
| SCHEMBL28376879 | 0.85 | CYP4F2 (0.63) | POLBSMN1; SMN2NPC1CYP4F2CYP4A11 | |
| SCHEMBL17479491 | 0.84 | LMNA (0.52) | POLBSMN1; SMN2TDP1LMNANPC1 | |
| SCHEMBL17459869 | 0.84 | CES2 (0.57) | POLBSMN1; SMN2TDP1LMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117946303-A | Catalyst, preparation method thereof, method for regulating and controlling ethylene polymerization kinetics behavior and application | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2023212597-A1 | CARBON DIOXIDE CAPTURE AND UTILIZATION AS A CLEAN FEEDSTOCK | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2023-11-02 | — | — | WO | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| EP-0647615-B1 | Process for the preparation of 5-fluoroanthranilic acid alkyl esters and or 5-fluoroanthranilic acid | HOECHST AG (DE) | 1997-05-28 | — | — | EP | claimed |
| US-5543550-A | NITRATING ALKYL ESTER OF 3-FLUOROBENZOIC ACID DISSOLVED IN SOLVENT-FREE SULFURIC ACID, THEN ADDING WATER, SEPARATION, HYDROLYSIS, PRESSURIZED CATALYTIC HYDROGENATION OF THE NITRATED ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-08-06 | — | — | US | claimed |
| US-20250188626-A1 | CARBON DIOXIDE CAPTURE AND UTILIZATION AS A CLEAN FEEDSTOCK | UNIV MICHIGAN TECH (US) | 2025-06-12 | — | — | US | disclosed |
| CN-120058445-A | Method for generating aryl phenol compound by hydroxylation of uranium photocatalytic aryl fluorine compound and application of method | 华东师范大学 | 2025-05-30 | — | — | CN | disclosed |
| CN-117946303-A | Catalyst, preparation method thereof, method for regulating and controlling ethylene polymerization kinetics behavior and application | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117946304-A | Spherical catalyst component containing fluoroester electron donor, preparation method, catalyst and application thereof in ethylene polymerization | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| WO-2023212597-A1 | CARBON DIOXIDE CAPTURE AND UTILIZATION AS A CLEAN FEEDSTOCK | MICHIGAN TECHNOLOGICAL UNIVERSITY (US) | 2023-11-02 | — | — | WO | disclosed |
| EP-3183250-B1 | PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL | CLAP CO LTD (KR) | 2023-10-04 | — | — | EP | disclosed |
| CN-113912597-B | ROR gamma inhibitor, preparation method and medical application thereof | 赛诺哈勃药业（成都）有限公司 | 2023-06-13 | — | — | CN | disclosed |
| US-20020161227-A1 | PROCESS FOR PREPARATION OF SUBSTITUTED AROMATIC COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2002-10-31 | — | — | US | disclosed |
| US-6469224-B1 | REACTING A PHOSPHAZENIUM COMPOUND WITH A HALOGENATED AROMATIC COMPOUNDS, ESPECIALLY CHLORINATED AROMATIC COMPOUNDS | MITSUI CHEMICALS, INC. (JP) | 2002-10-22 | — | — | US | disclosed |
| US-5543550-A | NITRATING ALKYL ESTER OF 3-FLUOROBENZOIC ACID DISSOLVED IN SOLVENT-FREE SULFURIC ACID, THEN ADDING WATER, SEPARATION, HYDROLYSIS, PRESSURIZED CATALYTIC HYDROGENATION OF THE NITRATED ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-08-06 | — | — | US | disclosed |
| US-5446190-A | Process for the preparation of alkyl fluorobenzoates in high purity and high yield | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-08-29 | — | — | US | disclosed |
| US-4333940-A | Ring-fluorinated 4-(monosubstituted-amino) phenyl compounds in inhibiting atherosclerotic lesion development | AMERICAN CYANAMID COMPANY (US) | 1982-06-08 | — | — | US | disclosed |
| US-4243609-A | ANTILIPEMIC AGENTS, ANTIATHEROSCLEROTIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1981-01-06 | — | — | US | disclosed |
| EP-0003663-A2 | Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-08-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | POLB 1829/4885SMN1; SMN2 4265/4885TDP1 3713/4885 |
| US-20020161227-A1 | PROCESS FOR PREPARATION OF SUBSTITUTED AROMATIC COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AFF1, PAH | POLB 460/4885SMN1; SMN2 3858/4885TDP1 2061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.